SCHEMBL20176495

SCHEMBL20176495

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc(-c5ccc6c7ccc8ccccc8c7n(-c7ccccc7)c6c5)nc4)c4ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
KHK P50053 1/20 0.32
MTOR P42345 2/20 0.31
KMT2A Q03164 3/20 0.31
MAPT P10636 2/20 0.31
MEN1 O00255 2/20 0.31
HSP90AA1 P07900 1/20 0.31
ALDH1A1 P00352 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
ESR1 P03372 2/20 0.31
ESR2 Q92731 2/20 0.31
AVPR1A P37288 1/20 0.31
CYP11B1 P15538 2/20 0.31
CYP11B2 P19099 2/20 0.31
KDM4E B2RXH2 1/20 0.31
ATM Q13315 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
NPC1 O15118 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26160954 0.99 HSD17B1 (0.34) HSD17B1HSD17B2KHKMTORKMT2A
SCHEMBL26161222 0.94 KHK (0.34) HSD17B1HSD17B2KHKMTORKMT2A
SCHEMBL20176538 0.93 HSD17B1 (0.33) HSD17B1HSD17B2MTORKMT2AESR1
SCHEMBL26161039 0.92 KHK (0.34) HSD17B1HSD17B2KHKMTORKMT2A
SCHEMBL26160955 0.91 HSD17B1 (0.33) HSD17B1HSD17B2MTORKMT2AMAPT
SCHEMBL20176513 0.89 MTOR (0.34) HSD17B1HSD17B2KHKMTORKMT2A
SCHEMBL26160957 0.89 MTOR (0.34) HSD17B1HSD17B2KHKMTORKMT2A
SCHEMBL20176490 0.87 ESR1 (0.37) HSD17B1HSD17B2KMT2AMAPTMEN1
SCHEMBL20176489 0.86 L3MBTL1 (0.45) HSD17B1HSD17B2KMT2AMAPTMEN1
SCHEMBL20176512 0.86 PTGES (0.32) HSD17B1HSD17B2KMT2AMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2023-06-06 US disclosed
WO-2018093231-A1 ORGANIC LIGHT EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME 주식회사 두산 2018-05-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11667622-B2 Organic light emitting compound and organic electroluminescence device using same OR10J3, ICMT, SLCO4C1 HSD17B1 1993/4885HSD17B2 2055/4885KHK 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.